Literature DB >> 11579387

Correlation of human papillomavirus 16 and 18 with cervical neoplasia in histological typing and clinical stage in Taiwan: an in-situ polymerase chain reaction approach.

J S Shyu1, C J Chen, C C Chiu, S C Huang, H J Harn.   

Abstract

BACKGROUND AND OBJECTIVES: In situ polymerase chain reaction (ISPCR) promises to considerably enhance our ability to detect a few copies of target nucleic acid sequences in fixed tissues and cells. The aim of this study was to investigate cervical carcinoma to determine the human papillomavirus (HPV) types on paraffin-embedded tissue sections by ISPCR and standard in situ hybridization. The results will correlate the morphological characteristics of lesions with viral typing results.
METHODS: This study examined prevalence of HPV 16 and 18 DNA in biopsies from 85 cervical cancer patients by ISPCR, employing HPV 16, 18 consensus primers. There are 45 patients with squamous cell carcinomas, 13 with adenocarcinoma, 2 with adenosquamous carcinomas, 3 with small cell carcinomas, and 22 carcinoma in situ. The relation between the types of HPV detected, tumor type, and clinical stage were analyzed.
RESULTS: Fifty-two of 85 biopsies were HPV 16- or 18-positive, HPV 16 being the most prevalent type. Squamous cell carcinoma had a high prevalence of HPV 16 and adenocarcinoma had a high prevalence of HPV 18. HPV 18 was the predominant type among high clinical stage (III-IV) cases while HPV 16 and mixed HPV 16 with HPV18 were significantly correlated with low clinical stage (0-I-II).
CONCLUSION: Our results indicate that certain malignant cervical tumor phenotypes and stages correlate with specific HPV type, and that ISPCR is a sensitive and fast method to detect HPV in these patients. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11579387     DOI: 10.1002/jso.1128

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  3 in total

1.  The prevalence of human papillomavirus infection in Korean non-small cell lung cancer patients.

Authors:  Moo Suk Park; Yoon Soo Chang; Ju Hye Shin; Dae Joon Kim; Kyung Young Chung; Dong Hwan Shin; Jin Wook Moon; Shin Myung Kang; Chang Hoon Hahn; Young Sam Kim; Joon Chang; Sung Kyu Kim; Se Kyu Kim
Journal:  Yonsei Med J       Date:  2007-02-28       Impact factor: 2.759

2.  Contribution of Human papillomavirus in neuroendocrine tumors from a series of 10,575 invasive cervical cancer cases.

Authors:  Maria Alejo; Laia Alemany; Omar Clavero; Beatriz Quiros; Susana Vighi; Muhieddine Seoud; Chou Cheng-Yang; Suzanne M Garland; Nuria Juanpere; Josep Lloreta; Sara Tous; Jo Ellen Klaustermeier; Wim Quint; F Xavier Bosch; Silvia de Sanjosé; Belen Lloveras
Journal:  Papillomavirus Res       Date:  2018-03-17

3.  Papanicolaou tests and molecular analyses using new fluid-based specimen collection technology in 3000 Japanese women.

Authors:  N Masumoto; T Fujii; M Ishikawa; M Mukai; M Saito; T Iwata; T Fukuchi; K Kubushiro; K Tsukazaki; S Nozawa
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.